<!DOCTYPE html>
<!--
==============================================================================
           "GitHub HTML5 Pandoc Template" v2.1 — by Tristano Ajmone           
==============================================================================
Copyright © Tristano Ajmone, 2017, MIT License (MIT). Project's home:

- https://github.com/tajmone/pandoc-goodies

The CSS in this template reuses source code taken from the following projects:

- GitHub Markdown CSS: Copyright © Sindre Sorhus, MIT License (MIT):
  https://github.com/sindresorhus/github-markdown-css

- Primer CSS: Copyright © 2016-2017 GitHub Inc., MIT License (MIT):
  http://primercss.io/

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
The MIT License 

Copyright (c) Tristano Ajmone, 2017 (github.com/tajmone/pandoc-goodies)
Copyright (c) Sindre Sorhus <sindresorhus@gmail.com> (sindresorhus.com)
Copyright (c) 2017 GitHub Inc.

"GitHub Pandoc HTML5 Template" is Copyright (c) Tristano Ajmone, 2017, released
under the MIT License (MIT); it contains readaptations of substantial portions
of the following third party softwares:

(1) "GitHub Markdown CSS", Copyright (c) Sindre Sorhus, MIT License (MIT).
(2) "Primer CSS", Copyright (c) 2016 GitHub Inc., MIT License (MIT).

Permission is hereby granted, free of charge, to any person obtaining a copy
of this software and associated documentation files (the "Software"), to deal
in the Software without restriction, including without limitation the rights
to use, copy, modify, merge, publish, distribute, sublicense, and/or sell
copies of the Software, and to permit persons to whom the Software is
furnished to do so, subject to the following conditions:

The above copyright notice and this permission notice shall be included in all
copies or substantial portions of the Software.

THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,
FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE
AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER
LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,
OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE
SOFTWARE.
==============================================================================-->
<html>
<head>
  <meta charset="utf-8" />
  <meta name="generator" content="pandoc" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
  <title>Asthma v3.0 MeG-CLS-001</title>
  <style type="text/css">
@charset "UTF-8";.markdown-body{-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;color:#24292e;font-family:-apple-system,system-ui,BlinkMacSystemFont,"Segoe UI",Helvetica,Arial,sans-serif,"Apple Color Emoji","Segoe UI Emoji","Segoe UI Symbol";font-size:16px;line-height:1.5;word-wrap:break-word;box-sizing:border-box;min-width:200px;max-width:980px;margin:0 auto;padding:45px}.markdown-body a{color:#0366d6;background-color:transparent;text-decoration:none;-webkit-text-decoration-skip:objects}.markdown-body a:active,.markdown-body a:hover{outline-width:0}.markdown-body a:hover{text-decoration:underline}.markdown-body a:not([href]){color:inherit;text-decoration:none}.markdown-body strong{font-weight:600}.markdown-body h1,.markdown-body h2,.markdown-body h3,.markdown-body h4,.markdown-body h5,.markdown-body h6{margin-top:24px;margin-bottom:16px;font-weight:600;line-height:1.25}.markdown-body h1{font-size:2em;margin:.67em 0;padding-bottom:.3em;border-bottom:1px solid #eaecef}.markdown-body h2{padding-bottom:.3em;font-size:1.5em;border-bottom:1px solid #eaecef}.markdown-body h3{font-size:1.25em}.markdown-body h4{font-size:1em}.markdown-body h5{font-size:.875em}.markdown-body h6{font-size:.85em;color:#6a737d}.markdown-body img{border-style:none}.markdown-body svg:not(:root){overflow:hidden}.markdown-body hr{box-sizing:content-box;height:.25em;margin:24px 0;padding:0;overflow:hidden;background-color:#e1e4e8;border:0}.markdown-body hr::before{display:table;content:""}.markdown-body hr::after{display:table;clear:both;content:""}.markdown-body input{margin:0;overflow:visible;font:inherit;font-family:inherit;font-size:inherit;line-height:inherit}.markdown-body [type=checkbox]{box-sizing:border-box;padding:0}.markdown-body *{box-sizing:border-box}.markdown-body blockquote{margin:0}.markdown-body ol,.markdown-body ul{padding-left:2em}.markdown-body ol ol,.markdown-body ul ol{list-style-type:lower-roman}.markdown-body ol ol,.markdown-body ol ul,.markdown-body ul ol,.markdown-body ul ul{margin-top:0;margin-bottom:0}.markdown-body ol ol ol,.markdown-body ol ul ol,.markdown-body ul ol ol,.markdown-body ul ul ol{list-style-type:lower-alpha}.markdown-body li>p{margin-top:16px}.markdown-body li+li{margin-top:.25em}.markdown-body dd{margin-left:0}.markdown-body dl{padding:0}.markdown-body dl dt{padding:0;margin-top:16px;font-size:1em;font-style:italic;font-weight:600}.markdown-body dl dd{padding:0 16px;margin-bottom:16px}.markdown-body code{font-family:SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace}.markdown-body pre{font:12px SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace;word-wrap:normal}.markdown-body blockquote,.markdown-body dl,.markdown-body ol,.markdown-body p,.markdown-body pre,.markdown-body table,.markdown-body ul{margin-top:0;margin-bottom:16px}.markdown-body blockquote{padding:0 1em;color:#6a737d;border-left:.25em solid #dfe2e5}.markdown-body blockquote>:first-child{margin-top:0}.markdown-body blockquote>:last-child{margin-bottom:0}.markdown-body table{display:block;width:100%;overflow:auto;border-spacing:0;border-collapse:collapse}.markdown-body table th{font-weight:600}.markdown-body table td,.markdown-body table th{padding:6px 13px;border:1px solid #dfe2e5}.markdown-body table tr{background-color:#fff;border-top:1px solid #c6cbd1}.markdown-body table tr:nth-child(2n){background-color:#f6f8fa}.markdown-body img{max-width:100%;box-sizing:content-box;background-color:#fff}.markdown-body code{padding:.2em 0;margin:0;font-size:85%;background-color:rgba(27,31,35,.05);border-radius:3px}.markdown-body code::after,.markdown-body code::before{letter-spacing:-.2em;content:" "}.markdown-body pre>code{padding:0;margin:0;font-size:100%;word-break:normal;white-space:pre;background:0 0;border:0}.markdown-body .highlight{margin-bottom:16px}.markdown-body .highlight pre{margin-bottom:0;word-break:normal}.markdown-body .highlight pre,.markdown-body pre{padding:16px;overflow:auto;font-size:85%;line-height:1.45;background-color:#f6f8fa;border-radius:3px}.markdown-body pre code{display:inline;max-width:auto;padding:0;margin:0;overflow:visible;line-height:inherit;word-wrap:normal;background-color:transparent;border:0}.markdown-body pre code::after,.markdown-body pre code::before{content:normal}.markdown-body .full-commit .btn-outline:not(:disabled):hover{color:#005cc5;border-color:#005cc5}.markdown-body kbd{box-shadow:inset 0 -1px 0 #959da5;display:inline-block;padding:3px 5px;font:11px/10px SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace;color:#444d56;vertical-align:middle;background-color:#fcfcfc;border:1px solid #c6cbd1;border-bottom-color:#959da5;border-radius:3px;box-shadow:inset 0 -1px 0 #959da5}.markdown-body :checked+.radio-label{position:relative;z-index:1;border-color:#0366d6}.markdown-body .task-list-item{list-style-type:none}.markdown-body .task-list-item+.task-list-item{margin-top:3px}.markdown-body .task-list-item input{margin:0 .2em .25em -1.6em;vertical-align:middle}.markdown-body::before{display:table;content:""}.markdown-body::after{display:table;clear:both;content:""}.markdown-body>:first-child{margin-top:0!important}.markdown-body>:last-child{margin-bottom:0!important}.Alert,.Error,.Note,.Success,.Warning{padding:11px;margin-bottom:24px;border-style:solid;border-width:1px;border-radius:4px}.Alert p,.Error p,.Note p,.Success p,.Warning p{margin-top:0}.Alert p:last-child,.Error p:last-child,.Note p:last-child,.Success p:last-child,.Warning p:last-child{margin-bottom:0}.Alert{color:#246;background-color:#e2eef9;border-color:#bac6d3}.Warning{color:#4c4a42;background-color:#fff9ea;border-color:#dfd8c2}.Error{color:#911;background-color:#fcdede;border-color:#d2b2b2}.Success{color:#22662c;background-color:#e2f9e5;border-color:#bad3be}.Note{color:#2f363d;background-color:#f6f8fa;border-color:#d5d8da}.Alert h1,.Alert h2,.Alert h3,.Alert h4,.Alert h5,.Alert h6{color:#246;margin-bottom:0}.Warning h1,.Warning h2,.Warning h3,.Warning h4,.Warning h5,.Warning h6{color:#4c4a42;margin-bottom:0}.Error h1,.Error h2,.Error h3,.Error h4,.Error h5,.Error h6{color:#911;margin-bottom:0}.Success h1,.Success h2,.Success h3,.Success h4,.Success h5,.Success h6{color:#22662c;margin-bottom:0}.Note h1,.Note h2,.Note h3,.Note h4,.Note h5,.Note h6{color:#2f363d;margin-bottom:0}.Alert h1:first-child,.Alert h2:first-child,.Alert h3:first-child,.Alert h4:first-child,.Alert h5:first-child,.Alert h6:first-child,.Error h1:first-child,.Error h2:first-child,.Error h3:first-child,.Error h4:first-child,.Error h5:first-child,.Error h6:first-child,.Note h1:first-child,.Note h2:first-child,.Note h3:first-child,.Note h4:first-child,.Note h5:first-child,.Note h6:first-child,.Success h1:first-child,.Success h2:first-child,.Success h3:first-child,.Success h4:first-child,.Success h5:first-child,.Success h6:first-child,.Warning h1:first-child,.Warning h2:first-child,.Warning h3:first-child,.Warning h4:first-child,.Warning h5:first-child,.Warning h6:first-child{margin-top:0}h1.title,p.subtitle{text-align:center}h1.title.followed-by-subtitle{margin-bottom:0}p.subtitle{font-size:1.5em;font-weight:600;line-height:1.25;margin-top:0;margin-bottom:16px;padding-bottom:.3em}div.line-block{white-space:pre-line}
  </style>
  <style type="text/css">code{white-space: pre;}</style>
  <!--[if lt IE 9]>
    <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.7.3/html5shiv-printshiv.min.js"></script>
  <![endif]-->
<script src="myScript.js"></script><link rel="stylesheet" href="myStyle.css"></head>
<body> <div w3-include-html="panel.html"></div> <script> includeHTML(); </script>
<article class="markdown-body">
<h1 id="asthma">Asthma</h1>
<h2 id="executive-summary"><em>Executive summary</em></h2>
<h2 id="introduction">Introduction</h2>
<p>Asthma is a very common, <a href="https://en.wikipedia.org/wiki/Chronic_(medicine)">long-term</a>, <a href="https://en.wikipedia.org/wiki/Inflammation">inflammatory</a> disease of the <a href="https://en.wikipedia.org/wiki/Bronchi">airways</a> of the lungs, characterized by variable and recurring symptoms, inflammation, reversible <a href="https://en.wikipedia.org/wiki/Airway_obstruction">airflow</a> <a href="https://en.wikipedia.org/wiki/Airway_obstruction">obstruction</a>, and <a href="https://en.wikipedia.org/wiki/Bronchospasm">bronchospasm</a>. Symptoms include episodes of <a href="https://en.wikipedia.org/wiki/Wheezing">wheezing</a>, <a href="https://en.wikipedia.org/wiki/Coughing">coughing</a>, chest tightness, and <a href="https://en.wikipedia.org/wiki/Shortness_of_breath">shortness of breath</a>. These episodes may occur a few times a day or a few times per week. Depending on the person, they may become worse at night or with exercise.</p>
<p>It is thought to be caused by a combination of <a href="https://en.wikipedia.org/wiki/Genetics">genetic</a> and <a href="https://en.wikipedia.org/wiki/Environmental_factor">environmental factors</a> (e.g. exposure to <a href="https://en.wikipedia.org/wiki/Air_pollution">air pollution</a> and <a href="https://en.wikipedia.org/wiki/Allergen">allergens</a>). Other potential triggers include medications such as <a href="https://en.wikipedia.org/wiki/Aspirin">aspirin</a> and <a href="https://en.wikipedia.org/wiki/Beta_blockers">beta blockers</a>. Diagnosis is usually based on the pattern of symptoms, response to therapy over time, and <a href="https://en.wikipedia.org/wiki/Spirometry">spirometry</a> or peak flow</p>
<p>There is no cure for asthma. Symptoms can be prevented by avoiding triggers, such as <a href="https://en.wikipedia.org/wiki/Allergens">allergens</a> and <a href="https://en.wikipedia.org/wiki/Irritation">irritants</a>, and by the use of inhaled <a href="https://en.wikipedia.org/wiki/Corticosteroid">corticosteroids</a>.</p>
<h2 id="target-users">Target users</h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Doctors</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Nurses</p>
</div></li>
</ul>
<h2 id="target-area-of-use">Target area of use</h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Gate clinic</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Outpatients</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Ward</p>
</div></li>
</ul>
<h2 id="key-areas-of-focus-new-additions-changes">Key areas of focus / New additions / Changes</h2>
<p>This guideline addresses the management of both acute and chronic asthma. It gives guidance on the immediate management of the acutely ill patient in gate clinic and the ongoing management of such patients on the ward.</p>
<p>It provides an asthma management plan to encourage literate patients to self-manage their asthma.</p>
<p>It advocates the use of inhalers rather than oral medications – given the increased effectiveness and reduced side-effects associated with this treatment.</p>
<h2 id="limitations">Limitations</h2>
<p>There is no access to arterial blood gases or to intubation for severely ill patients with asthma.</p>
<h2 id="presenting-symptoms-and-signs">Presenting symptoms and signs</h2>
<table>
<thead>
<tr class="header">
<th></th>
<th><div data-custom-style="Table Paragraph">
<p><strong>Life threatening</strong></p>
</div></th>
<th><div data-custom-style="Table Paragraph">
<blockquote>
<p><strong>Acute severe</strong></p>
</blockquote>
</div></th>
<th><div data-custom-style="Table Paragraph">
<blockquote>
<p><strong>Moderately exacerbated</strong></p>
</blockquote>
</div></th>
<th><div data-custom-style="Table Paragraph">
<blockquote>
<p><strong>Mild</strong></p>
</blockquote>
</div></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><div data-custom-style="Table Paragraph">
<p><strong>Dyspnoea</strong></p>
</div></td>
<td><div data-custom-style="Table Paragraph">
<p>At rest</p>
</div></td>
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p>At rest</p>
</blockquote>
</div></td>
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p>When talking</p>
</blockquote>
</div></td>
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p>With activity</p>
</blockquote>
</div></td>
</tr>
<tr class="even">
<td><div data-custom-style="Table Paragraph">
<p><strong>Speech</strong></p>
</div></td>
<td><div data-custom-style="Table Paragraph">
<p>Mute</p>
</div></td>
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p>Difficult</p>
</blockquote>
</div></td>
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p>Difficulty completing</p>
</blockquote>
</div>
<div data-custom-style="Table Paragraph">
<blockquote>
<p>sentences</p>
</blockquote>
</div></td>
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p>Can complete sentences</p>
</blockquote>
</div></td>
</tr>
<tr class="odd">
<td><div data-custom-style="Table Paragraph">
<p><strong>Body position</strong></p>
</div></td>
<td><div data-custom-style="Table Paragraph">
<p>Unable to recline</p>
</div></td>
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p>Unable to recline, restless</p>
</blockquote>
</div></td>
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p>Sitting up</p>
</blockquote>
</div></td>
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p>Able to recline</p>
</blockquote>
</div></td>
</tr>
<tr class="even">
<td><div data-custom-style="Table Paragraph">
<p><strong>Respiratory rate</strong></p>
</div></td>
<td><div data-custom-style="Table Paragraph">
<p>&gt;30 /min – feeble effort</p>
</div></td>
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p>Often &gt; 25 /min</p>
</blockquote>
</div></td>
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p>Increased</p>
</blockquote>
</div></td>
<td></td>
</tr>
<tr class="odd">
<td><div data-custom-style="Table Paragraph">
<p><strong>Use of accessory muscles</strong></p>
</div></td>
<td><div data-custom-style="Table Paragraph">
<p>Paradoxical thoraco-</p>
</div>
<div data-custom-style="Table Paragraph">
<p>abdominal movements</p>
</div></td>
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p>Increased use</p>
</blockquote>
</div></td>
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p>Yes</p>
</blockquote>
</div></td>
<td></td>
</tr>
<tr class="even">
<td><div data-custom-style="Table Paragraph">
<p><strong>Breath sounds</strong></p>
</div></td>
<td><div data-custom-style="Table Paragraph">
<p>Near silent or silent chest</p>
</div></td>
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p>Loud inspiratory and expiratory wheeze</p>
</blockquote>
</div></td>
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p>Loud expiratory wheeze</p>
</blockquote>
</div></td>
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p>Moderate wheeze at mid to end expiration</p>
</blockquote>
</div></td>
</tr>
<tr class="odd">
<td><div data-custom-style="Table Paragraph">
<p><strong>Heart rate</strong></p>
</div></td>
<td><div data-custom-style="Table Paragraph">
<p>Relative bradycardia &lt; 50/min</p>
</div></td>
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p>Tachycardia &gt; 110 /minute</p>
</blockquote>
</div></td>
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p>&gt; 100 /min</p>
</blockquote>
</div></td>
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p>&lt; 100 /min</p>
</blockquote>
</div></td>
</tr>
<tr class="even">
<td><div data-custom-style="Table Paragraph">
<p><strong>Blood pressure</strong></p>
</div></td>
<td><div data-custom-style="Table Paragraph">
<p>Hypotension</p>
</div></td>
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p>Normotensive in most cases</p>
</blockquote>
</div></td>
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p>Normotensive</p>
</blockquote>
</div></td>
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p>Normotensive</p>
</blockquote>
</div></td>
</tr>
<tr class="odd">
<td><div data-custom-style="Table Paragraph">
<p><strong>Mental status</strong></p>
</div></td>
<td><div data-custom-style="Table Paragraph">
<p>Confused or drowsy</p>
</div></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><div data-custom-style="Table Paragraph">
<p><strong>PEFR (% of</strong></p>
</div>
<div data-custom-style="Table Paragraph">
<p><strong>predicted)</strong></p>
</div></td>
<td><div data-custom-style="Table Paragraph">
<p>&lt; 33%</p>
</div></td>
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p>33-50%</p>
</blockquote>
</div></td>
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p>50-80%</p>
</blockquote>
</div></td>
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p>&gt; 80%</p>
</blockquote>
</div></td>
</tr>
<tr class="odd">
<td><div data-custom-style="Table Paragraph">
<p><strong>Oxygen saturation</strong></p>
</div></td>
<td><div data-custom-style="Table Paragraph">
<p>&lt; 92%</p>
</div></td>
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p>≥ 92%</p>
</blockquote>
</div></td>
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p>&gt; 95%</p>
</blockquote>
</div></td>
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p>&gt; 95%</p>
</blockquote>
</div></td>
</tr>
<tr class="even">
<td><div data-custom-style="Table Paragraph">
<p><strong>ECG</strong></p>
</div></td>
<td><div data-custom-style="Table Paragraph">
<p>Arrhythmia</p>
</div></td>
<td></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
<h3 id="brittle-asthma">Brittle asthma</h3>
<p>Defined by either:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Wide peak flow variability (&gt; 40% diurnal variation for more than 50% of the time over a period of &gt; 150 days) despite intense therapy</p>
</div></li>
</ul>
<div data-custom-style="List Paragraph">
<p>OR</p>
</div>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Sudden severe attacks on a background of apparently well-controlled asthma</p>
</div></li>
</ul>
<h2 id="investigation-of-acute-severe-asthma">Investigation of acute severe asthma</h2>
<p><strong>Peak flow</strong> – when expressed as a percentage of the patient’s previous best value is most useful clinically</p>
<p><strong>Pulse Oximetry</strong> – measurement of oxygen saturation with a pulse oximeter is necessary to determine the adequacy of oxygen therapy</p>
<p><strong>Chest x-ray</strong> – recommended in patients with:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Suspected pneumomediastinum or pneumothorax</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Suspected consolidation</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Life-threatening asthma</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Failure to respond to treatment satisfactorily</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Requirement for ventilation.</p>
</div></li>
</ul>
<p>Arterial blood gases are desirable but not currently available.</p>
<h2 id="management-in-gate-clinic">Management in Gate Clinic</h2>
<p>Anyone with saturations below 92%, very little air entry, poor respiratory effort, reduced conscious level, reduced blood pressure, arrhythmia has life-threatening asthma and <strong><em>the doctor should be called to see them immediately</em>.</strong></p>
<p>Look out for common symptoms and signs of asthma: cough, difficulty with breathing, dyspnea, difficulty speaking in full sentences, sitting up/unable to recline.</p>
<p>Once you suspect asthma, examine for auscultatory wheeze (if life threatening, chest may be silent).</p>
<h3 id="bronchodilators">Bronchodilators</h3>
<p>Nebulize immediately if there is anything other than mild asthma with Salbutamol 2.5 mg in children, 5 mg in adults, double diluted with water for injection or normal saline, nebulization may be repeated every 20 minutes in the first hour till the patient feels relief.</p>
<p><strong>During the COVID pandemic</strong>, nebulizer use should be avoided as much as possible due to risk of transmitting infection to health care workers and other patients. Use of pressurised metered dose inhaler and spacer with a mouth piece or tightly fitting face mask.</p>
<p>Also give these patients a salbutamol inhaler with a spacer. Ensure that the patient and their family understand when to use the inhaler and how to use it. Advise them to use the inhaler whenever they are short of breath. Explain that they should always use the spacer to ensure the full dose of medication reaches their lungs and that they do not suffer side effects. If they need to use it more than 3 times in a day, then they should seek medical help. Also advise them to take 10 puffs of the inhaler via the spacer if they become acutely breathless. They should then seek medical help.</p>
<h3 id="steroids">Steroids</h3>
<p>Give a course of steroids to all patients with a clear diagnosis of asthma, who do not have signs of severe asthma and who improve after nebulization. Give prednisolone 40 mg OD for 5 days to adults and 2 mg/kg (max 40 mg) OD for 3 days to children.</p>
<h3 id="refer-to-the-doctor-if">Refer to the doctor if:</h3>
<ul>
<li><div data-custom-style="List Paragraph">
<p>you are unsure of the diagnosis</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>there is any of fever, weight loss, general body pain, failure to thrive, any unexplained clinical findings, vomiting or chronic productive cough.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>the patient has not improved after nebulization.</p>
</div></li>
</ul>
<h2 id="management-in-opd">Management in OPD</h2>
<p>Look out for common symptoms and signs of asthma: cough, difficulty with breathing, dyspnoea, difficulty speaking in full sentences, sitting up/unable to recline.</p>
<p>Once you suspect asthma, do a quick assessment: including a quick general examination and a quick respiratory exam (including pulse oximetry).</p>
<p>Send for nebulization and/or admission as necessary. If stable after nebulization, consider managing as outpatient with short follow-up period.</p>
<h3 id="stable-asthma-management">Stable asthma management</h3>
<p>For patients with stable asthma use the asthma action plan to help them manage their asthma in the long run.</p>
<p>Give these patients a salbutamol inhaler with a spacer. Ensure that the patient and their family understand when to use the inhaler and how to use it. Advise them to use the inhaler whenever they are short of breath. Explain that they should always use the spacer to ensure the full dose of medication reaches their lungs and that they do not suffer side effects. If they need to use it more than 3 times in a day, then they should seek medical help. Also advise them to take 10 puffs of the inhaler via the spacer if they become acutely breathless. They should then seek medical help.</p>
<p>Ideally, adolescents and adults with asthma should not receive treatment with short-acting bronchodilators alone, instead they should receive either symptom driven (in mild asthma) or regular prevention treatment with daily inhaled corticosteroid (ICS) to reduce the risk of severe exacerbations, reduce the frequency and severity of asthma symptoms and risk of flare ups. Unfortunately, most cannot afford this treatment at present.</p>
<h2 id="management-on-the-ward">Management on the ward</h2>
<p>Admit the patient if:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Respiratory fatigue and suspected airway infection</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Presence of pneumothorax</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Hypotensive</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>History of status epilepticus</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Persisting or worsening hypoxia</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Drowsiness and confusion</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Exhaustion, feeble respiratory effort</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>ECG abnormalities (supraventricular arrhythmias, multifocal atria tachycardia, conduction disturbances, ventricular ectopics).</p>
</div></li>
</ul>
<h3 id="mild-to-moderate-exacerbation">Mild to moderate exacerbation</h3>
<p>Move to acute care room or emergency bed.</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Every 15 minutes monitor pulse oximetry and vital signs electronically.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Give <strong>continuous humidified oxygen</strong>. Target saturation 93-95% (children 94-98%.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Rehydrate if dehydrated or hypotensive using 0.9% Normal Saline at maintenance level.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p><strong>Inhaled short-acting bronchodilator</strong>: Nebulise with Salbutamol (5 mg in 5 mls of Normal saline or 2.5 mg in 2.5mls Normal saline for children). OR spacer repeated doses at 4-10 puffs of bronchodilator via inhaler and spacer administered frequently up to 3 times every 20 minutes within the first hour, assess response at 1 hour or earlier.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p><strong>Prednisolone:</strong> early oral corticosteroid 30-50mg OD (1-2mg/kg OD max 40mg in children.</p>
</div>
<ul>
<li><div data-custom-style="List Paragraph">
<p>IV Hydrocortisone 200 mg 6 hourly (4mg/kg/dose in children 6 hourly) is reserved for patients unable to take oral medications.</p>
</div></li>
</ul></li>
</ul>
<h3 id="severe-exacerbation">Severe exacerbation</h3>
<p>Remember to exclude anaphylaxis and tension pneumothorax.</p>
<p><strong>Inhaled anticholinergic ipratropium bromide</strong> is a useful add on to a ß2 agonist in older children &gt; 6 years old when symptoms are severe, but is not routinely available.</p>
<p>Consider giving a <strong>single dose of IV Magnesium Sulphate</strong> (1.2-2 g IV MgSO<sub>4</sub> in 100 ml 0.9% saline over 20 minutes) for patients with acute severe asthma that have not had a good initial <em>response to inhaled bronchodilator therapy or have life threatening</em> or near fatal asthma.</p>
<p><strong>Subcutaneous adrenaline</strong> (1: 10,000 solution) 0.1 – 0.3 ml in the young and 1 ml in the adult can be used for those that do not respond despite all the measures above.</p>
<p>Intravenous aminophylline is unlikely to result in any additional bronchodilation in actue asthma compared to standard immediate treatment with nebulised ß<sub>2</sub>-agonist bronchodilators and oral steroids. Some patients with near fatal asthma or life threatening asthma with a poor response to initial therapy may gain additional benefit from iv aminophylline.</p>
<p>Give a single iv dose of aminophylline 5 mg/kg over 30 minutes only if the patient has not received oral theophylline or aminophylline within the last 24 hours.</p>
<p>Add 500 mg aminophylline (20 ml volume to 500 ml 0.9% saline after removing 20 ml from the bag of saline (concentration: 500 mg in 500ml = 1 mg/ml). Run the infusion for 30 minutes.</p>
<p>Do not use a maintenance infusion unless it is absolutely necessary as we cannot measure aminophylline levels.</p>
<p>Consider referral for intubation if in <strong>impending respiratory failure</strong> – no sedation to be given.</p>
<h2 id="asthma-action-plan">ASTHMA ACTION PLAN</h2>
<table>
<thead>
<tr class="header">
<th><div data-custom-style="Table Paragraph">
<p><strong>Name:</strong></p>
</div></th>
<th><div data-custom-style="Table Paragraph">
<blockquote>
<p><strong>My Asthma Severity:</strong></p>
</blockquote>
</div></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p><strong>GO</strong></p>
</blockquote>
</div>
<div data-custom-style="Table Paragraph">
<p>I feel good</p>
</div>
<div data-custom-style="Table Paragraph">
<p>No cough or wheeze</p>
</div>
<div data-custom-style="Table Paragraph">
<p>I can work, sleep &amp; play without symptoms</p>
</div>
<div data-custom-style="Table Paragraph">
<p>My peak flow number is above</p>
</div>
<div data-custom-style="Table Paragraph">
<blockquote>
<p>__________</p>
</blockquote>
</div></td>
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p><strong>Green Zone</strong> : Asthma in good Control</p>
</blockquote>
</div>
<ol type="1">
<li><div data-custom-style="Table Paragraph">
<p>Take your asthma preventer inhaler everyday: <strong>Seretide/ Beclomethasone</strong> inhaler 2 puffs twice a day (gargle with warm water after)</p>
</div></li>
<li><div data-custom-style="Table Paragraph">
<p>Avoid your triggers as much as possible</p>
</div></li>
<li><div data-custom-style="Table Paragraph">
<p>If you are about to something really physically demanding, use <strong>Salbutamol</strong> inhaler 2 puffs 15 minutes before starting and 2 puffs during the activity if you have symptoms.</p>
</div></li>
</ol></td>
</tr>
<tr class="even">
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p><strong>SLOW</strong></p>
</blockquote>
</div>
<div data-custom-style="Table Paragraph">
<p>I have any one of these:</p>
</div>
<ul>
<li><div data-custom-style="Table Paragraph">
<p>I do not feel good</p>
</div></li>
<li><div data-custom-style="Table Paragraph">
<p>Cough or wheeze</p>
</div></li>
<li><div data-custom-style="Table Paragraph">
<p>Chest feels tight</p>
</div></li>
<li><div data-custom-style="Table Paragraph">
<p>Waking up at night</p>
</div></li>
<li><div data-custom-style="Table Paragraph">
<p>Difficulty working, playing or sleeping</p>
</div></li>
</ul>
<div data-custom-style="Table Paragraph">
<p>My peak flow number is between</p>
</div>
<div data-custom-style="Table Paragraph">
<blockquote>
<p>__________ and __________</p>
</blockquote>
</div></td>
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p><strong>Yellow Zone</strong>: Asthma is getting worse</p>
</blockquote>
</div>
<ol type="1">
<li><div data-custom-style="Table Paragraph">
<p>Keep taking your green zone inhalers.</p>
</div></li>
<li><div data-custom-style="Table Paragraph">
<p>Start your reliever/rescue inhaler <strong>Salbutamol Inhaler</strong> 2 puffs every 20 minutes for up to one hour. Then every 4 hours for 24-48 hours.</p>
</div></li>
<li><div data-custom-style="Table Paragraph">
<p>If you do not return to the green zone in 12 hours, or you get worse, start taking <strong>Prednisolone</strong> 40 mg once daily for 5 days.</p>
</div></li>
<li><div data-custom-style="Table Paragraph">
<p>If you stay in yellow zone for more than 12 hours, go to the clinic ASAP.</p>
</div></li>
</ol></td>
</tr>
<tr class="odd">
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p><strong>STOP</strong></p>
</blockquote>
</div>
<div data-custom-style="Table Paragraph">
<p>I have any one of the following:</p>
</div>
<ul>
<li><div data-custom-style="Table Paragraph">
<p>Very short of breath. Cannot sleep, walk, work, talk or play</p>
</div></li>
<li><div data-custom-style="Table Paragraph">
<p>Severe wheezing, coughing hard</p>
</div></li>
<li><div data-custom-style="Table Paragraph">
<p>Chest tightness</p>
</div></li>
<li><div data-custom-style="Table Paragraph">
<p>Blueness of skin of lips, tiredness due to effort of breathing</p>
</div></li>
</ul>
<div data-custom-style="Table Paragraph">
<p>My peak flow number is less than</p>
</div>
<div data-custom-style="Table Paragraph">
<blockquote>
<p>___________</p>
</blockquote>
</div></td>
<td><div data-custom-style="Table Paragraph">
<blockquote>
<p><strong>Red Zone</strong>-Medical Alert- Get Help FAST</p>
</blockquote>
</div>
<ol type="1">
<li><div data-custom-style="Table Paragraph">
<p>Take reliever immediately or get nebulised every 10-15 minutes.</p>
</div></li>
<li><div data-custom-style="Table Paragraph">
<p>Get to health facility FAST.</p>
</div></li>
</ol></td>
</tr>
</tbody>
</table>
<h2 id="references">References</h2>
<p>Asthma: diagnosis, monitoring and chronic asthma management, NICE NG80, November 2017. <a href="https://www.nice.org.uk/guidance/ng80"><span class="underline">https://www.nice.org.uk/guidance/ng80</span></a> (accessed 4 June 2018).</p>
<p>National Asthma Education and Prevention Program Expert Panel Report 3: Guidelines for the diagnosis and management of Asthma. <a href="https://www.nhlbi.nih.gov/sites/default/files/media/docs/asthsumm.pdf"><span class="underline">https://www.nhlbi.nih.gov/sites/default/files/media/docs/asthsumm.pdf</span></a></p>
<p>Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2020 <a href="https://ginasthma.org/reports/"><span class="underline">https://ginasthma.org/reports/</span></a> (accessed Dec 14, 2020).</p>
<table>
<thead>
<tr class="header">
<th><strong>Written by:</strong></th>
<th>Name: Babatunde Awokola</th>
<th>Date: 29 June 2018</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Reviewed by:</strong></td>
<td>Name: Karen Forrest</td>
<td>Date: 25 July 2018</td>
</tr>
<tr class="even">
<td><strong>Reviewed by</strong></td>
<td>Name Baderinwa Abatan</td>
<td>Date 30 July 2020</td>
</tr>
<tr class="odd">
<td><strong>Version:</strong></td>
<td><strong>Change history:</strong></td>
<td><strong>Review due date:</strong></td>
</tr>
<tr class="even">
<td>1.0</td>
<td>New document</td>
<td></td>
</tr>
<tr class="odd">
<td>2.0</td>
<td>Rewritten to expand relevance beyond gate clinic</td>
<td>31 July 2020</td>
</tr>
<tr class="even">
<td>2.1</td>
<td>Executive summary added</td>
<td>31 July 2020</td>
</tr>
<tr class="odd">
<td>3.0</td>
<td>Additional information about replacing nebulization with inhaler and spacer during COVID-19 outbreak</td>
<td><em>18</em> December 2022</td>
</tr>
<tr class="even">
<td>Review Comments (<em>if applicable)</em></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
</article>
</body>
</html>
